The combination of BRAFV600E mutation and Chinese Thyroid Imaging Reporting and Data System is helpful in the management of AUS/FLUS thyroid nodules

B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, et al., 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016). https://doi.org/10.1089/thy.2015.0020

Article  PubMed  PubMed Central  Google Scholar 

M. Bongiovanni, A. Spitale, W.C. Faquin, L. Mazzucchelli, Z.W. Baloch, The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol. 56(4), 333–339 (2012). https://doi.org/10.1159/000339959

Article  PubMed  Google Scholar 

C.C. Wang, L. Friedman, G.C. Kennedy, H. Wang, E. Kebebew, D.L. Steward, et al., A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid 21(3), 243–251 (2011). https://doi.org/10.1089/thy.2010.0243

Article  PubMed  PubMed Central  Google Scholar 

N.P. Ohori, K.E. Schoedel, Variability in the atypia of undetermined significance/follicular lesion of undetermined significance diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: sources and recommendations. Acta Cytol. 55(6), 492–498 (2011). https://doi.org/10.1159/000334218

Article  PubMed  Google Scholar 

Z.W. Baloch, V.A. LiVolsi, S.L. Asa, J. Rosai, M.J. Merino, G. Randolph, et al., Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-needle Aspiration State of the Science Conference. Diagn. Cytopathol. 36(6), 425–437 (2008). https://doi.org/10.1002/dc.20830

Article  PubMed  Google Scholar 

E.S. Cibas, S.Z. Ali, The 2017 Bethesda System for Reporting Thyroid Cytopathology. J. Am. Soc. Cytopathol. 6(6), 217–222 (2017). https://doi.org/10.1016/j.jasc.2017.09.002

Article  PubMed  Google Scholar 

K.J. Brister, R.S. Singh, H.H. Wang, Reporting thyroid FNA before and after implementation of the Bethesda system-one institution’s experience. Diagn. Cytopathol. 43(1), 28–31 (2015). https://doi.org/10.1002/dc.23182

Article  PubMed  Google Scholar 

R. Nayar, M. Ivanovic, The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer 117(3), 195–202 (2009). https://doi.org/10.1002/cncy.20029

Article  PubMed  Google Scholar 

R.L. Ferris, Z. Baloch, V. Bernet, A. Chen, T.J. Fahey 3rd, I. Ganly, et al., American Thyroid Association statement on surgical application of molecular profiling for thyroid nodules: current impact on perioperative decision making. Thyroid 25(7), 760–768 (2015). https://doi.org/10.1089/thy.2014.0502

Article  PubMed  PubMed Central  Google Scholar 

M. Xing, BRAF mutation in thyroid cancer. Endocr. Relat. Cancer 12(2), 245–262 (2005). https://doi.org/10.1677/erc.1.0978

Article  CAS  PubMed  Google Scholar 

M. Xing, B.R. Haugen, M. Schlumberger, Progress in molecular-based management of differentiated thyroid cancer. Lancet 381(9871), 1058–1069 (2013). https://doi.org/10.1016/S0140-6736(13)60109-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

C. Ferraz, M. Eszlinger, R. Paschke, Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J. Clin. Endocrinol. Metab. 96(7), 2016–2026 (2011). https://doi.org/10.1210/jc.2010-2567

Article  CAS  PubMed  Google Scholar 

Y. Cohen, M. Xing, E. Mambo, Z. Guo, G. Wu, B. Trink, et al., BRAF mutation in papillary thyroid carcinoma. J. Natl. Cancer Inst. 95(8), 625–627 (2003). https://doi.org/10.1093/jnci/95.8.625

Article  CAS  PubMed  Google Scholar 

E.K. Alexander, G.C. Kennedy, Z.W. Baloch, E.S. Cibas, D. Chudova, J. Diggans, et al., Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N. Engl. J. Med. 367(8), 705–715 (2012). https://doi.org/10.1056/NEJMoa1203208

Article  CAS  PubMed  Google Scholar 

G. Grani, L. Lamartina, V. Ascoli, D. Bosco, F. Nardi, F. D’Ambrosio et al., Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules. Endocrine 57(2), 256–261 (2017). https://doi.org/10.1007/s12020-016-1148-6

Article  CAS  PubMed  Google Scholar 

J. Zhou, L. Yin, X. Wei, S. Zhang, Y. Song, B. Luo, et al., 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS. Endocrine 70(2), 256–279 (2020). https://doi.org/10.1007/s12020-020-02441-y

Article  CAS  PubMed  Google Scholar 

J. Zhou, Y. Song, W. Zhan, X. Wei, S. Zhang, R. Zhang, et al., Thyroid imaging reporting and data system (TIRADS) for ultrasound features of nodules: multicentric retrospective study in China. Endocrine 72(1), 157–170 (2021). https://doi.org/10.1007/s12020-020-02442-x

Article  CAS  PubMed  Google Scholar 

Q. Qi, A. Zhou, S. Guo, X. Huang, S. Chen, Y. Li, et al., Explore the diagnostic efficiency of Chinese Thyroid Imaging Reporting and Data Systems by comparing with the other four systems (ACR TI-RADS, Kwak-TIRADS, KSThR-TIRADS, and EU-TIRADS): a single-center study. Front Endocrinol. 12, 763897 (2021). https://doi.org/10.3389/fendo.2021.763897

Article  Google Scholar 

H. Gharib, E. Papini, J.R. Garber, D.S. Duick, R.M. Harrell, L. Hegedus, et al., American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules–2016 update. Endocr. Pract. 22(5), 622–639 (2016). https://doi.org/10.4158/EP161208.GL

Article  PubMed  Google Scholar 

R.M. Tuttle, B. Haugen, N.D. Perrier, Updated American Joint Committee on Cancer/tumor-node-metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?. Thyroid 27(6), 751–756 (2017). https://doi.org/10.1089/thy.2017.0102

Article  PubMed  PubMed Central  Google Scholar 

M. Bongiovanni, L. Giovanella, F. Romanelli, P. Trimboli, Cytological diagnoses associated with noninvasive Follicular thyroid neoplasms with Papillary-like nuclear features according to the Bethesda system for reporting thyroid Cytopathology: a systematic review and meta-analysis. Thyroid 29(2), 222–228 (2019). https://doi.org/10.1089/thy.2018.0394

Article  PubMed  Google Scholar 

X. Zhu, X. Peng, L. Zhu, L. Xie, F. Cheng, B. Zhou, Evaluation of the diagnostic performance of contrast-enhanced ultrasound combined with BRAF V600E gene detection in nodules of unclear significance by thyroid fine-needle aspiration. Gland Surg. 10(1), 328–335 (2021). https://doi.org/10.21037/gs-20-705

Article  PubMed  PubMed Central  Google Scholar 

D.S. Cohen, J.E. Tongson-Ignacio, C.M. Lolachi, V.S. Ghaderi, B. Jahan-Parwar, L.D.R. Thompson, Rethinking malignancy risk in indeterminate thyroid nodules with positive molecular studies: Southern California permanente experience. Otolaryngol. Head Neck Surg. 161(3), 419–423 (2019). https://doi.org/10.1177/0194599819842859

Article  PubMed  Google Scholar 

Y.F. Zhou, Y.F. Zhang, H.J. Fu, W.P. Yang, C.K. Zhao, H.X. Xu, Improving the diagnosis of AUS/FLUS thyroid nodules using an algorithm with combination of BRAFV600E mutation analysis and ultrasound pattern-based risk stratification. Clin. Hemorheol. Microcirc. 77(3), 273–285 (2021). https://doi.org/10.3233/CH-200985

Article  CAS  PubMed  Google Scholar 

M. Rho, E.K. Kim, H.J. Moon, J.H. Yoon, V.Y. Park, K. Han, et al., Clinical parameter for deciding the BRAFV600E mutation test in Atypia of undetermined significance/Follicular lesion of undetermined significance thyroid nodules: US features according to TIRADS. Ultrasound Q. 33(4), 284–288 (2017). https://doi.org/10.1097/RUQ.0000000000000313

Article  PubMed  Google Scholar 

Y.J. Suh, Y.J. Choi, Strategy to reduce unnecessary surgeries in thyroid nodules with cytology of Bethesda category III (AUS/FLUS): a retrospective analysis of 667 patients diagnosed by surgery. Endocrine 69(3), 578–586 (2020). https://doi.org/10.1007/s12020-020-02300-w

Article  CAS  PubMed  Google Scholar 

T.Y. Kim, W.B. Kim, J.Y. Song, Y.S. Rhee, G. Gong, Y.M. Cho, et al., The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin. Endocrinol. 63(5), 588–593 (2005). https://doi.org/10.1111/j.1365-2265.2005.02389.x

Article  CAS  Google Scholar 

K.W. Chung, S.K. Yang, G.K. Lee, E.Y. Kim, S. Kwon, S.H. Lee, et al., Detection of BRAF V600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF V600E mutation-prevalent area. Clin. Endocrinol. 65(5), 660–666 (2006). https://doi.org/10.1111/j.1365-2265.2006.02646.x

Article  CAS  Google Scholar 

M.M. DiLorenzo, J.L. Miller, M. Tuluc, Z.X. Wang, V.W. Savarese, E.A. Pribitkin, False-positive FNA due to highly sensitive BRAF assay. Endocr. Pract. 20(1), E8–E10 (2014). https://doi.org/10.4158/Ep13294.Cr

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif